Repurposed Drug Could Open Door to More Stem Cell Transplants

News   Dec 21, 2017 | Original story from University of British Columbia

 
Repurposed Drug Could Open Door to More Stem Cell Transplants

This is Peter Zandstra, director of UBC's School of Biomedical Engineering and Michael Smith Laboratories, and chief scientific officer of the Centre for Commercialization of Regenerative Medicine. Credit: UBC/Paul Joseph

 
 
 

RELATED ARTICLES

High-Stakes Cellular Process Critical to Small Intestine Development

News

Researchers visualize an intricate cellular dance which occurs during embryonic gut development

READ MORE

New Tool for Generating Mature Kidney Podocytes

News

New protocol produces large numbers of mature human podocytes, enabling further kidney disease research

READ MORE

Fetal Gene Therapy Prevents Lethal Neurodegenerative Disease

News

Researchers have successfully prevented the development of a fatal neurodegenerative disorder, Gaucher disease, using fetal gene therapy, in mice. The study highlights the potential of using this approach to combat lethal neurodegenerative diseases affecting newborns.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy